REBECCA XI: Open Payments
NPI 1316364599 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 13 payments from 8 companies in 2025. Trend: 2023 $374 · 2024 $663 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 3 | $77 |
| Alexion Pharmaceuticals, Inc. | 3 | $63 |
| ABBVIE INC. | 2 | $61 |
| PFIZER INC. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Shionogi Inc | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: Kcentra, ULTOMIRIS, DALVANCE, VYNDAQEL, ELIQUIS, Fetroja, JOURNAVX, XIFAXAN.
Industry payments across TX — which companies pay providers there.
